The ATRIA score is superior to the m-CHA2DS2-Vasc score in predicting in-hospital mortality in COVID-19

SUMMARY OBJECTIVE: Coronavirus disease 2019 (COVID-19) has become a health and social problem all over the world. Most of deaths occur from embolism thrombus formation. We aimed to compare predictive value anticoagulation risk factors in atrial fibrillation (ATRIA) m-CHA2DS2-Vasc scores in-hospital mortality COVID-19. METHODS: Three-hundred ninety-four patients who were hospitalized due COVID-19 between 10 June 2020 September included. sixty survived defined as non-mortality group remaining 34 whose hospitalizations resulted death group. The calculated. RESULTS: A total 394 patients, mean age 66.2±9.7 (221 male [56.1%]) included this retrospective study. median values different groups (p<0.000 for both). multivariate logistic regression analysis showed that both independent predictors (p=0.024, 95%CI 1.039–1.704 p=0.043, 1.012–2.088 m-CHA2DS2-Vasc). In receiver operating characteristic curve analysis, score was superior with an AUC 0.774 SE:0.037, p<0.001. CONCLUSIONS: our study, we can be used thrombosis patients. addition, higher than m-CHA2DS2-Vasc. use assess high-risk may recommended.